Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06064422 · ClinicalTrials.gov registry record · NA

Adapting BA for Minimally Verbal Autistic Adults

A NA study of Depression and Autism Spectrum Disorder, sponsored by Rutgers, The State University of New Jersey.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06064422: Active NA study of Depression and Autism Spectrum Disorder, sponsored by Rutgers, The State University of New Jersey.

NCT06064422 is a NA study of Depression and Autism Spectrum Disorder that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 15 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06064422, a NA study of Depression and Autism Spectrum Disorder, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The present study aims to adapt and evaluate the feasibility of the BeatIt-2 behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with minimally verbal autistic individuals.

Primary Outcome

The GDS is a 20-item self- and caregiver-reported questionnaire of psychological function over the past week with all items on a "0" (Never/No) to 2 (Always/A lot) scale. Higher scores equal more distress. Scores range from 0-32. The expected change is a decrease in the score.

Conditions Studied

Depression Autism Spectrum Disorder Autism Autism Spectrum Disorder With Impaired Functional Language

Interventions

  • BEHAVIORAL BeatIt-MV

Study Locations (1)

New Jersey

  • Rutgers University - New Brunswick - Piscataway

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-11-01
Est. Completion 2025-08-30
Phase NA
Rutgers, The State University of New Jersey

413 total trials

What the registry record for NCT06064422 still lists

NCT06064422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which BeatIt-MV is the first listed.

NCT06064422 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06064422 about?

NCT06064422 is a clinical study titled "Adapting BA for Minimally Verbal Autistic Adults". The present study aims to adapt and evaluate the feasibility of the BeatIt-2 behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with minimally verbal autistic individuals.

What is the current status of trial NCT06064422?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-11-01. Estimated completion is 2025-08-30.

What conditions does trial NCT06064422 study?

This clinical trial studies the following conditions: Depression, Autism Spectrum Disorder, Autism, Autism Spectrum Disorder With Impaired Functional Language.

What interventions are being tested in trial NCT06064422?

The interventions under investigation include: BeatIt-MV (BEHAVIORAL).

Who is sponsoring clinical trial NCT06064422?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06064422 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06064422's enrollment target sits among peer trials

15 641st of 679 higher than 33 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Related registry views

Source: ClinicalTrials.gov NCT06064422, the US trial registry maintained by the National Library of Medicine. NCT06064422 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.